UNIVERSIDAD NACIONAL DE COLOMBIA
- Country
- 🇨🇴Colombia
- Ownership
- Private
- Established
- 1967-09-22
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.unal.edu.co
Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 4078
- Registration Number
- NCT04887246
- Locations
- 🇨🇴
Universidad Nacional de Colombia, Bogotá, Colombia
Randomized, Controlled, Double Blind, to Evaluate the Postpartum Analgesia With Epidural Morphine: Analgesic Effect of Two Different Doses Compared to Placebo
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 114
- Registration Number
- NCT04887649
- Locations
- 🇨🇴
Universidad Nacional; Maternal and Child Institute, Bogota, Colombia
Personalized Vaccine for Cancer Immunotherapy
- Conditions
- Interventions
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 9
- Registration Number
- NCT04879888
- Locations
- 🇨🇴
Facultad de Medicina - Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia
Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia)
- Conditions
- Interventions
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 210
- Registration Number
- NCT04877626
- Locations
- 🇨🇴
San Rafael Hospital in Quibdó Chocó, Quibdó, Chocó, Colombia
Cefuroxime Resistance in Pyelonephritis
- Conditions
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 973
- Registration Number
- NCT04616352
- Locations
- 🇨🇴
Clínica Reina Sofía, Bogota, DC, Colombia
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
- Conditions
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 650
- Registration Number
- NCT04359095
- Locations
- 🇨🇴
Clinica Universitaria Colombia, Bogotá, Colombia
🇨🇴Clínica Reina Sofía, Bogotá, Colombia
🇨🇴Fundacion Cardio Infantil, Bogotá, Colombia
Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19
- First Posted Date
- 2020-04-15
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Universidad Nacional de Colombia
- Registration Number
- NCT04346329
- Locations
- 🇨🇴
Facultad de Medicina - Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia
🇨🇴Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia
Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Universidad Nacional de Colombia
- Registration Number
- NCT04344548
- Locations
- 🇨🇴
Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia
🇨🇴Fundacion Salud De Los Andes, Bogotá, Bogotá Distrito Capital, Colombia
Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells
- Conditions
- Interventions
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 5
- Registration Number
- NCT04105582
- Locations
- 🇨🇴
Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia
Therapeutic Effect of Two Muscle Strengthening Programs in Patients With Patellofemoral Pain Syndrome
- Conditions
- Interventions
- First Posted Date
- 2019-07-08
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Universidad Nacional de Colombia
- Target Recruit Count
- 40
- Registration Number
- NCT04011436
- Locations
- 🇨🇴
Universidad Nacional de Colombia, Bogotá, Colombia